Atlas Trials

JIANG LONGWEI

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch JIANG LONGWEI

RecordFirmDate
Efficacy and Safety Study of DC-CIK Cell Therapy Combined With Epaloliposide, Vortexil, and Regorafenib as Third-line Treatment for Advanced Colorectal Cancer. (NCT07343791)JIANG LONGWEI2025-11-19
A Single-arm, Open, Exploratory Clinical Study of Allogeneic CAR-T Cells in the Treatment of Relapsed/Refractory Brain Gliomas With Positive CD70 Expression (NCT06828341)JIANG LONGWEI2024-06-13
A Clinical Study of Albumin-bound Paclitaxel/Granulocyte-based Therapy for Recurrent/Metastatic Breast Cancer (NCT06496724)JIANG LONGWEI2024-06-01
A Study of Tumor Neoantigen-specific T Cells in the Treatment of Advanced Solid Tumors (NCT06431529)JIANG LONGWEI2024-04-18

Track JIANG LONGWEI automatically

Every clearance here is in the API, with alerts when new ones post.